Logotipo do repositório
 

Publicação:
Cost-effectiveness of imatinib versus interferon-alpha in the treatment of patients newly diagnosed with chronic myeloid leukemia, under the Brazilian public healthcare system perspective.

Página do item simplificado
dc.contributor.authorMataveli, Fabio
dc.contributor.authorCalabro, Alessandra
dc.contributor.authorMendes, Wellington
dc.contributor.authorVianna, Denizar
dc.contributor.authorDorlhiac-Llacer, Pedro
dc.contributor.authorBigni, Ricardo
dc.contributor.authorHungria, Vania
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.contributor.institutionNovartis Biociencias S A
dc.contributor.institutionUniversidade Federal do Rio de Janeiro (UFRJ)
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionNatl Canc Inst
dc.contributor.institutionSan Casa São Paulo
dc.date.accessioned2014-05-20T15:25:59Z
dc.date.available2014-05-20T15:25:59Z
dc.date.issued2006-11-16
dc.description.affiliationUniv Fed São Paulo, São Paulo, Brazil
dc.description.affiliationNovartis Biociencias S A, São Paulo, Brazil
dc.description.affiliationUniv Rio de Janeiro, Rio de Janeiro, Brazil
dc.description.affiliationState Univ São Paulo, Fundação Pro Sangue, São Paulo, Brazil
dc.description.affiliationNatl Canc Inst, Rio de Janeiro, Brazil
dc.description.affiliationSan Casa São Paulo, São Paulo, Brazil
dc.description.affiliationUnespState Univ São Paulo, Fundação Pro Sangue, São Paulo, Brazil
dc.format.extent946A-946A
dc.identifierhttp://abstracts.hematologylibrary.org/cgi/content/abstract/108/11/3314
dc.identifier.citationBlood. Washington: Amer Soc Hematology, v. 108, n. 11, p. 946A-946A, 2006.
dc.identifier.issn0006-4971
dc.identifier.urihttp://hdl.handle.net/11449/36287
dc.identifier.wosWOS:000242440004362
dc.language.isoeng
dc.publisherAmer Soc Hematology
dc.relation.ispartofBlood
dc.relation.ispartofjcr15.132
dc.relation.ispartofsjr6,434
dc.rights.accessRightsAcesso restrito
dc.sourceWeb of Science
dc.titleCost-effectiveness of imatinib versus interferon-alpha in the treatment of patients newly diagnosed with chronic myeloid leukemia, under the Brazilian public healthcare system perspective.en
dc.typeResumo
dcterms.licensehttp://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml
dcterms.rightsHolderAmer Soc Hematology
dspace.entity.typePublication

Arquivos

Licença do Pacote

Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição:

Coleções

Artigos